Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)
This grant opportunity supports research on how two or more vaccine adjuvants work together to enhance immune response. The aim is to understand their mechanisms and ultimately create better vaccines by predicting how these combinations will affect the immune system. Eligible adjuvants must have previously shown that they can modify immune activity.
The purpose of this notice of funding opportunity (NOFO) is to support research studies of two or more vaccine adjuvants (combination adjuvants) in order to understand the mechanisms by which they work in concert. All adjuvants considered must have previously demonstrated immune modulating activ…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers